525 related articles for article (PubMed ID: 21942498)
1. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
3. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
He X; Hai L; Su J; Wang K; Wu X
Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
[TBL] [Abstract][Full Text] [Related]
4. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
Alexander CM; Dabrowiak JC; Maye MM
Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
9. DNA-capped nanoparticles designed for doxorubicin drug delivery.
Alexander CM; Maye MM; Dabrowiak JC
Chem Commun (Camb); 2011 Mar; 47(12):3418-20. PubMed ID: 21286626
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
11. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
12. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen.
Chen SJ; Huang CC; Chang HT
Talanta; 2010 Apr; 81(1-2):493-8. PubMed ID: 20188952
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
Zhang X; Chibli H; Mielke R; Nadeau J
Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
[TBL] [Abstract][Full Text] [Related]
14. A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.
Qiao G; Zhuo L; Gao Y; Yu L; Li N; Tang B
Chem Commun (Camb); 2011 Jul; 47(26):7458-60. PubMed ID: 21589964
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Taghdisi SM; Abnous K; Mosaffa F; Behravan J
J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
[TBL] [Abstract][Full Text] [Related]
17. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles.
Wang X; Cai X; Hu J; Shao N; Wang F; Zhang Q; Xiao J; Cheng Y
J Am Chem Soc; 2013 Jul; 135(26):9805-10. PubMed ID: 23789713
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
[TBL] [Abstract][Full Text] [Related]
20. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]